Anesthesiology Doctors in Placerville, CA Accepting Medicare

7 Anesthesiology doctors found. Showing 1 - 7

Robert Jarka, M.D. Anesthesiology - Pain Medicine Medicare: Medicare Enrolled Practice Location: 4300 Golden Center Dr, Suite E, Placerville, CA 95667 Phone: 530-344-1680

Gary Cutter, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1100 Marshall Way, Placerville, CA 95667 Phone: 530-622-1441

Dr. Gerald Young Choi, D.O. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1100 Marshall Way, Anesthesia Dept., Placerville, CA 95667 Phone: 530-622-1441

Roy Cronnelly, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1100 Marshall Way, Placerville, CA 95667 Phone: 530-622-1441

Michael Murphy, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1100 Marshall Way, Placerville, CA 95667 Phone: 530-622-1441

Caroline Wigan, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1100 Marshall Way, Placerville, CA 95667 Phone: 530-622-1441    Fax: 530-621-2165

Joanne Coen, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: 1100 Marshall Way, Placerville, CA 95667 Phone: 530-622-1441

News Archive

Smoking during pregnancy increases risk of birth defects and neurological disorders

Mothers who smoke are more likely to deliver smaller babies even after a full-term pregnancy, increasing the risks of birth defects and neurological disorders later in life, say researchers from McGill University.

Beyond Pay-for-Performance: A free Webinar to help hospitals improve patient care

Attend the free Webinar, "Beyond Pay-for-Performance," and learn how today's national performance improvement efforts are helping hospitals improve patient care and reduce costs - and discover the tactics and strategies behind top-performing hospitals and health systems.

NellOne's lead candidate for skeletal muscle wound healing and myocardial infarction demonstrates potential efficacy

Two key, independent proof-of-concept studies conducted for NellOne Therapeutics, Inc. demonstrate the potential efficacy of the company's lead therapeutic candidate for both skeletal muscle wound healing and myocardial infarction.

Research reveals tricyclic anti-depressants increase risk of CVD

Research that followed nearly 15,000 people in Scotland has shown that a class of older generation anti-depressant is linked to an increased risk of cardiovascular disease (CVD). The study showed that tricyclic anti-depressants were associated with a 35% increased risk of CVD, but that there was no increased risk with the newer anti-depressants such as the selective serotonin reuptake inhibitors (SSRIs).

Arena Pharmaceuticals presents data from its Phase 3 trial of LOrcaserin

Arena Pharmaceuticals, Inc. reported today data from the pivotal BLOSSOM (Behavioral modification and LOrcaserin Second Study for Obesity Management) Phase 3 trial that demonstrate improvements in patients' body composition, cardiovascular risk factors and quality of life. These findings add to the previously announced top-line BLOSSOM data that showed highly significant weight loss with lorcaserin over one year of treatment in 4,008 patients.

Read more Medical News

› Verified 4 days ago